TRANSCAT INC (TRNS) Fundamental Analysis & Valuation

NASDAQ:TRNS • US8935291075

70.67 USD
-4.19 (-5.6%)
At close: Mar 6, 2026
70.67 USD
0 (0%)
After Hours: 3/6/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This TRNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to TRNS. TRNS was compared to 47 industry peers in the Trading Companies & Distributors industry. TRNS has only an average score on both its financial health and profitability. TRNS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. TRNS Profitability Analysis

1.1 Basic Checks

  • TRNS had positive earnings in the past year.
  • TRNS had a positive operating cash flow in the past year.
  • In the past 5 years TRNS has always been profitable.
  • Each year in the past 5 years TRNS had a positive operating cash flow.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

  • TRNS has a Return On Assets (1.67%) which is in line with its industry peers.
  • TRNS has a Return On Equity (2.66%) which is in line with its industry peers.
  • TRNS has a Return On Invested Capital of 3.14%. This is comparable to the rest of the industry: TRNS outperforms 40.43% of its industry peers.
  • TRNS had an Average Return On Invested Capital over the past 3 years of 6.00%. This is below the industry average of 9.12%.
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROIC 3.14%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • With a Profit Margin value of 2.47%, TRNS perfoms like the industry average, outperforming 46.81% of the companies in the same industry.
  • In the last couple of years the Profit Margin of TRNS has grown nicely.
  • TRNS has a Operating Margin of 5.60%. This is comparable to the rest of the industry: TRNS outperforms 55.32% of its industry peers.
  • In the last couple of years the Operating Margin of TRNS has grown nicely.
  • With a decent Gross Margin value of 32.45%, TRNS is doing good in the industry, outperforming 63.83% of the companies in the same industry.
  • TRNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TRNS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRNS is destroying value.
  • TRNS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TRNS has more shares outstanding
  • The debt/assets ratio for TRNS is higher compared to a year ago.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 3.58 indicates that TRNS is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of TRNS (3.58) is better than 68.09% of its industry peers.
  • TRNS has a debt to FCF ratio of 4.02. This is a neutral value as TRNS would need 4.02 years to pay back of all of its debts.
  • TRNS has a Debt to FCF ratio of 4.02. This is in the better half of the industry: TRNS outperforms 63.83% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that TRNS is not too dependend on debt financing.
  • TRNS's Debt to Equity ratio of 0.34 is in line compared to the rest of the industry. TRNS outperforms 59.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Altman-Z 3.58
ROIC/WACC0.32
WACC9.68%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

  • TRNS has a Current Ratio of 2.21. This indicates that TRNS is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.21, TRNS is doing good in the industry, outperforming 65.96% of the companies in the same industry.
  • TRNS has a Quick Ratio of 1.85. This is a normal value and indicates that TRNS is financially healthy and should not expect problems in meeting its short term obligations.
  • TRNS has a Quick ratio of 1.85. This is in the better half of the industry: TRNS outperforms 76.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.85
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. TRNS Growth Analysis

3.1 Past

  • The earnings per share for TRNS have decreased by -9.19% in the last year.
  • Measured over the past 5 years, TRNS shows a small growth in Earnings Per Share. The EPS has been growing by 6.36% on average per year.
  • The Revenue has grown by 17.45% in the past year. This is quite good.
  • TRNS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.97% yearly.
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.15% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 8.45% on average over the next years. This is quite good.
EPS Next Y35.31%
EPS Next 2Y27.15%
EPS Next 3Y16.78%
EPS Next 5Y17.15%
Revenue Next Year19.21%
Revenue Next 2Y12.88%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. TRNS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 42.07 indicates a quite expensive valuation of TRNS.
  • Compared to the rest of the industry, the Price/Earnings ratio of TRNS indicates a slightly more expensive valuation: TRNS is more expensive than 61.70% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of TRNS to the average of the S&P500 Index (26.29), we can say TRNS is valued expensively.
  • With a Price/Forward Earnings ratio of 29.74, TRNS can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as TRNS.
  • When comparing the Price/Forward Earnings ratio of TRNS to the average of the S&P500 Index (24.57), we can say TRNS is valued slightly more expensively.
Industry RankSector Rank
PE 42.07
Fwd PE 29.74
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as TRNS.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TRNS indicates a somewhat cheap valuation: TRNS is cheaper than 68.09% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 26.51
EV/EBITDA 18.59
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • TRNS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as TRNS's earnings are expected to grow with 16.78% in the coming years.
PEG (NY)1.19
PEG (5Y)6.61
EPS Next 2Y27.15%
EPS Next 3Y16.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRNS Dividend Analysis

5.1 Amount

  • TRNS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRNS Fundamentals: All Metrics, Ratios and Statistics

TRANSCAT INC

NASDAQ:TRNS (3/6/2026, 8:00:02 PM)

After market: 70.67 0 (0%)

70.67

-4.19 (-5.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-03
Earnings (Next)05-18
Inst Owners98.89%
Inst Owner Change0.55%
Ins Owners0.99%
Ins Owner Change0.9%
Market Cap659.35M
Revenue(TTM)319.69M
Net Income(TTM)7.89M
Analysts80
Price Target103.36 (46.26%)
Short Float %5.17%
Short Ratio3.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.05%
Min EPS beat(2)-23.53%
Max EPS beat(2)-14.58%
EPS beat(4)2
Avg EPS beat(4)2.74%
Min EPS beat(4)-23.53%
Max EPS beat(4)46.44%
EPS beat(8)4
Avg EPS beat(8)4.49%
EPS beat(12)7
Avg EPS beat(12)2.23%
EPS beat(16)8
Avg EPS beat(16)1.87%
Revenue beat(2)2
Avg Revenue beat(2)0.8%
Min Revenue beat(2)0.17%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1.01%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.56%
Revenue beat(12)6
Avg Revenue beat(12)-1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)-2.25%
PT rev (3m)-8.09%
EPS NQ rev (1m)-3.82%
EPS NQ rev (3m)-9.74%
EPS NY rev (1m)-3.47%
EPS NY rev (3m)-13.62%
Revenue NQ rev (1m)1.63%
Revenue NQ rev (3m)2.62%
Revenue NY rev (1m)0.91%
Revenue NY rev (3m)2.37%
Valuation
Industry RankSector Rank
PE 42.07
Fwd PE 29.74
P/S 2.06
P/FCF 26.51
P/OCF 16.79
P/B 2.22
P/tB N/A
EV/EBITDA 18.59
EPS(TTM)1.68
EY2.38%
EPS(NY)2.38
Fwd EY3.36%
FCF(TTM)2.67
FCFY3.77%
OCF(TTM)4.21
OCFY5.96%
SpS34.26
BVpS31.81
TBVpS-0.29
PEG (NY)1.19
PEG (5Y)6.61
Graham Number34.67
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROCE 4.1%
ROIC 3.14%
ROICexc 3.17%
ROICexgc 10.29%
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
FCFM 7.78%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Debt/EBITDA 2.34
Cap/Depr 57.97%
Cap/Sales 4.51%
Interest Coverage 250
Cash Conversion 91.87%
Profit Quality 315.12%
Current Ratio 2.21
Quick Ratio 1.85
Altman-Z 3.58
F-Score4
WACC9.68%
ROIC/WACC0.32
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
EPS Next Y35.31%
EPS Next 2Y27.15%
EPS Next 3Y16.78%
EPS Next 5Y17.15%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%
Revenue Next Year19.21%
Revenue Next 2Y12.88%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%
EBIT growth 1Y-18.8%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year192.7%
EBIT Next 3Y47.62%
EBIT Next 5Y32.49%
FCF growth 1Y34.44%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y31.51%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 5 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 3 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


What is the profitability of TRNS stock?

TRANSCAT INC (TRNS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for TRNS stock?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 42.07 and the Price/Book (PB) ratio is 2.22.


What is the financial health of TRANSCAT INC (TRNS) stock?

The financial health rating of TRANSCAT INC (TRNS) is 5 / 10.